Dentsply Sirona Inc. · NASDAQ:XRAY
Dentsply Sirona — Q4 2025 Earnings Presentation
22 slides from Dentsply Sirona's earnings presentation, Feb 26, 2026
Slide 1: Fourth Quarter 2025 Earnings Conference Call
Fourth Quarter 2025 February 26, 2026 Earnings Conference Call
Slide 2: Forward-Looking Statements and Associated Risks
Forward-Looking Statements and Associated Risks All statements in this Presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause ac
Slide 3: Key Developments
Key Developments Full year 2025 constant currency sales (4.3%), Byte impact of (1.9%) to constant currency sales; adj. EBITDA margin 18.1% and adj. EPS $1.60, non-recurring +$0.13 to adj. EPS from Byte Signed new or expanded agreements with Patterson Dental, Benco Dental, Burkhart Dental Supply and
Slide 4: Fourth Quarter 2025 Financial Summary
Fourth Quarter 2025 Financial Summary Q4 2025 Q4 2024 YoY Commentary ▪ Net sales in constant currency +2.5% YoY, Net Sales $961M $905M +6.2% including 5.7% driven by Byte(1) and ERP comparable(2) Constant + EDS Currency +2.5% + OIS + Wellspect - CTS Adj. EBITDA $135M $128M +5.3% ▪ Adj. EPS $0.27, +4
Slide 5: Fourth Quarter 2025 Segment Results
Fourth Quarter 2025 Segment Results Constant Net Sales Commentary Currency Connected ▪ CAD/CAM (MSD): Lower volumes in Europe and Rest of World, partially offset by growth Technology $299M (1.9%) in the U.S. Solutions Reported: +1.8% (CTS) ▪ Equipment & Instruments +LSD: Imaging growth in the U.S. a
Slide 6: Full Year 2025 Financial Summary
Full Year 2025 Financial Summary FY 2025 FY 2024 YoY Commentary ▪ Net sales in constant currency (4.3%) YoY, Net Sales $3,680M $3,793M (3.0%) including (1.9%) Byte impact + Wellspect Constant - EDS Currency (4.3%) - CTS - OIS ▪ Adj. EBITDA margin 18.1%, +150 bps YoY Adj. EBITDA $667M $631M +5.6% • E
Slide 7: Return-to-Growth Action Plan
Return-to-Growth Action Plan 1 2 3 4 5 Customer-Centric Reigniting Empowering Scaling Financial Strength Mindset Sustainable Growth Performance Organization • Building strategic KOL • Accelerating innovation • Established • Initiating restructuring • Eliminated dividend to Advisory Boards to through
Slide 8: 2026 Outlook
2026 Outlook* Net Sales $3.5B to $3.6B Operational Growth (3%) to (1%) Adjusted EPS $1.40 to $1.50 Operational growth represents change in expected FY2026 net sales in constant currency when compared to FY2025, excluding net sales attributable to Byte and the anticipated impact of the new dealer inv
Slide 9: In Summary
In Summary “ Executing with urgency on Return-to-Growth Action Plan Increasing investment to accelerate clinical education, R&D, and sales team training Focusing on delivering sustained, profitable growth 9
Slide 10: Appendix
Appendix Dentsply S Sirona
Slide 11: Definitions
Non-GAAP Financial Measures Definitions Constant Currency Adjusted Gross Profit and Margin Reported net sales adjusted for the impact of foreign currency changes, which is Gross profit excluding the impact of any of the above adjustments that affect either calculated by translating current period ne
Slide 12: Trailing Nine Quarters
Trailing Nine Quarters In millions (except percentages) Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Net Sales $1,012 $953 $984 $951 $905 $879 $936 $904 $961 Adjusted EBITDA $173 $160 $173 $170 $128 $168 $197 $167 $135 Adj. EBITDA Margin % 17.1% 16.8% 17.5% 17.9% 14.2% 19.0% 21.1% 18.4% 14.
Slide 13: Net Sales as Reported and in Constant Currency Q4 2025 and Q4 2024
A reconciliation of the change in reported net sales to net sales in constant currency for the comparable period are as follows: Net Sales as Reported and in Constant Currency Q4 2025 and Q4 2024 (unaudited) 13
Slide 14: Net Sales as Reported and in Constant Currency FY 2025 and FY 2024
A reconciliation of the change in reported net sales to net sales in constant currency for the comparable period are as follows: Net Sales as Reported and in Constant Currency FY 2025 and FY 2024 (unaudited) 14
Slide 15: Reconciliation of Condensed Consolidated Statements of Operations
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations (unaudited) 15
Slide 16: Reconciliation of Condensed Consolidated Statements of Operations
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations (unaudited) 16
Slide 17: Reconciliation of Condensed Consolidated Statements of Operations
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations (unaudited) 17
Slide 18: Reconciliation of Condensed Consolidated Statements of Operations
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations (unaudited) 18
Slide 19: Reconciliation of Adjusted EBITDA
Reconciliation of Non-GAAP Financial Measures Adjusted EBITDA (unaudited) 19
Slide 20: Reconciliation of Adjusted EBITDA
Reconciliation of Non-GAAP Financial Measures Adjusted EBITDA (unaudited) 20
Slide 21: Reconciliation of Free Cash Flow
Reconciliation of Non-GAAP Financial Measures Free Cash Flow (unaudited) 21
Slide 22: Slide 22